YMRC
QDEL icon

Yorktown Management & Research Company’s QuidelOrtho QDEL Stock Holding History

Yorktown Management & Research Company’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,600
Closed -$265K – 236
2023
Q4 		$265K Hold
3,600
– – 0.28% 189
2023
Q3 		$263K Sell
3,600
-1,400
-28% -$112K 0.3% 183
2023
Q2 		$414K Hold
5,000
– – 0.45% 96
2023
Q1 		$445K Hold
5,000
– – 0.48% 81
2022
Q4 		$428K Buy
+5,000
New +$424K 0.52% 71

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Yorktown Management & Research Company's QDEL Position: Q1 2024 in Review

Yorktown Management & Research Company sold out of QuidelOrtho (QDEL) in Q1 2024, closing a stake of 3,600 shares — an estimated $265K sold.

Yorktown Management & Research Company first reported a position in QDEL in Q4 2022 and held it in 5 quarters. The position peaked at $445K in Q1 2023. 271 funds tracked by Wall St. Rank hold QDEL as of Q1 2024.

  • Yorktown Management & Research Company reported no remaining QuidelOrtho position as of Q1 2024 after selling out during the quarter.
  • Yorktown Management & Research Company sold 3,600 QuidelOrtho shares in Q1 2024, an estimated $265K.
  • Yorktown Management & Research Company first reported a position in QuidelOrtho in Q4 2022 and held it in 5 quarters.
  • Yorktown Management & Research Company's QuidelOrtho position peaked at $445K in Q1 2023.
  • 271 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2024.

Based on Yorktown Management & Research Company's 13F filing for Q1 2024, filed 26 Apr 2024.